- Home
- IART vs OLMA Comparison
IART vs OLMA Comparison
Compare IART & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IART | OLMA |
|---|---|---|
| Founded | 1989 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 949.3M |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IART | OLMA |
|---|---|---|
| Price | $13.20 | $7.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 12 |
| Target Price | $18.38 | ★ $36.50 |
| AVG Volume (30 Days) | 844.5K | ★ 1.1M |
| Earning Date | 10-29-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.83 | N/A |
| Revenue Next Year | $3.36 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.70 | $6.65 |
| 52 Week High | $20.49 | $36.26 |
Technical Indicators
Market Signals| Indicator | IART | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 27.98 | 24.76 |
| Support Level | $10.42 | N/A |
| Resistance Level | $14.12 | $11.27 |
| Average True Range (ATR) | 0.68 | 0.47 |
| MACD | -0.18 | -0.12 |
| Stochastic Oscillator | 19.25 | 0.00 |
Price Performance
Historical ComparisonAbout IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.